This phase III trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies ...
The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in ...
This phase II/III trial compares the addition of radiation therapy to the usual treatment (immunotherapy with or without chemotherapy) versus (vs.) usual treatment alone in treating patients with ...
#èÿ0#ioö ˆ¢>\DjÒ Õ™ ã†þøõçß_ ÆM|¬ó|Ÿjú}¿ME̶º,[v¬w!qâ8·óâä ŒÄ‘D›" ’²d lSü³o÷òmÖ ý }€ôÜ †9c 6s$ÙÉ ìé¸RÂjƒ‚‘ü$™„Å Ð{øœÖs‘Þ \ÇxÑ øê÷óÿÿ{åç«‹s ¦ÌD ñ±÷Jª QP " c~R# 0:Ì P±êüÿ{µä»›ÒQN`xBPm0ˆßûî ¿ H–À—mPA ...
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback